Two promising FTO inhibitors named as FB23 and FB23-2 were developed to selectively inhibit FTO’s m6A demethylase activity, which dramatically suppresses the proliferation and promotes apoptosis of AML cells250. The gene discussed is FTO; the disease is acute myeloid leukemia.